Pragmatic randomized controlled trial of non-pharmacological treatment for lumbar disc herniation : A pilot study

Jaseng Hospital of Korean Medicine0 个研究点目标入组 30 人开始时间: 待定最近更新: 2022年10月24日

适应症

试验速览

暂无简介。

•1. Numeric rating scale (NRS) score of radiating pain 5 or more for recent 3 serial days.
•2. Onset time of radiating pain occurred within 12 weeks.
•3. Radiologically diagnosed with lumbar disc herniation in lumbar spine magnetic resonance imaging (L-spine MRI)
•4. 19-70 years old
•5. participants who agreed and signed informed consent form

•1. Spine metastasis of cancer, acute fracture of spine, or spine dislocation
•2. Progressive neurologic deficits or severe neurologic deficits
•3. Soft tissue diseases that can induce low back pain(ie. cancer, fibromyalgia, rheumatoid arthritis, gout,etc)
•4. Presence of chronic underlying disease which can interfere the efficacy or interpretation (ie. stroke, myocardial infarct, kidney disease, dementia, diabetic neuropathy, epilepsy, etc)
•5. Concurrent use of steroids, immunosuppressants, orpsychotropic medications or any other medication that can interrupt the study result
•6. Hemorrhagic disease, severe diabetes or taking anticoagulant drug
•7. Participants who took NSAIDs or pharmacopuncture within 1 week
•8. Pregnant or lactating women
•9. Participants who had undergone lumbar surgery within 3 months
•10. Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
•11. Participants who can not write informed consent
•12. Participants who is difficult to participate in the trial according to investigator's decision

发起方

Jaseng Hospital of Korean Medicine